DOLENE Drug Patent Profile
Which patents cover Dolene, and what generic alternatives are available?
Dolene is a drug marketed by Heritage Pharms Inc and Lederle and is included in two NDAs.
The generic ingredient in DOLENE is acetaminophen; propoxyphene hydrochloride. There are two drug master file entries for this compound. Additional details are available on the acetaminophen; propoxyphene hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DOLENE?
- What are the global sales for DOLENE?
- What is Average Wholesale Price for DOLENE?
Summary for DOLENE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 16 |
| Patent Applications: | 2,726 |
| DailyMed Link: | DOLENE at DailyMed |
US Patents and Regulatory Information for DOLENE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heritage Pharms Inc | DOLENE | propoxyphene hydrochloride | CAPSULE;ORAL | 080530-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lederle | DOLENE AP-65 | acetaminophen; propoxyphene hydrochloride | TABLET;ORAL | 085100-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
